Alongside the development of vaccines there has been the development of treatments for COVID-19. Last year we had remdesivir which inhibits the activity of the virus and reduces recovery time. The drugs dexamethasone and tocilizumab both work as anti-inflammatories. This year we have sotrovimab which is a monoclonal antibody therapy.
ZG: 5
Somehow we don’t get excited about treatments the way we do about vaccines.
Read More